Silk Road Medical, Inc
Silk Road Medical, Inc., a pioneering medical device company headquartered in the United States, focuses on innovative solutions for carotid artery disease. Founded in 2007, the company has made significant strides in the vascular intervention industry, particularly with its flagship product, the ENROUTE Transcarotid Neuroprotection System. This unique system enhances patient safety during carotid artery procedures, setting Silk Road Medical apart in a competitive market. With a strong presence in North America and expanding operations in Europe, Silk Road Medical has established itself as a leader in the field of neuroprotection and minimally invasive vascular interventions. The company’s commitment to advancing patient care is reflected in its notable achievements, including FDA approvals and recognition for its contributions to improving surgical outcomes.
DitchCarbon Score
How does Silk Road Medical, Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Silk Road Medical, Inc's score of 58 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Silk Road Medical, Inc's reported carbon emissions
In 2023, Silk Road Medical, Inc. reported total carbon emissions of approximately 792,900 kg CO2e, comprising 205,000 kg CO2e from Scope 1 and 587,900 kg CO2e from Scope 2 emissions. This represents a reduction from 2022, where emissions were about 891,000 kg CO2e (290,000 kg CO2e from Scope 1 and 601,000 kg CO2e from Scope 2). The company has demonstrated a commitment to reducing its carbon footprint, as evidenced by the decrease in emissions over the past year. However, there are currently no specific reduction targets or initiatives disclosed, such as Science-Based Targets Initiative (SBTi) commitments or documented climate pledges. Silk Road Medical's emissions data is primarily focused on Scope 1 and Scope 2, with no reported Scope 3 emissions. The company continues to monitor and report its emissions, aligning with industry standards for transparency and accountability in climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 275,000 | 000,000 | 000,000 |
| Scope 2 | 525,500 | 000,000 | 000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Silk Road Medical, Inc is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
